Raj Shah
Concepts (341)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 45 | 2025 | 206 | 10.610 |
Why?
| Endoscopy, Digestive System | 22 | 2024 | 122 | 6.680 |
Why?
| Pancreatic Ducts | 21 | 2024 | 79 | 6.280 |
Why?
| Pancreatic Diseases | 14 | 2024 | 70 | 5.060 |
Why?
| Calculi | 8 | 2022 | 16 | 4.140 |
Why?
| Pancreatitis, Chronic | 11 | 2023 | 51 | 3.910 |
Why?
| Bile Duct Neoplasms | 13 | 2021 | 99 | 3.730 |
Why?
| Endosonography | 24 | 2023 | 143 | 3.390 |
Why?
| Lithotripsy | 10 | 2022 | 43 | 3.190 |
Why?
| Stents | 19 | 2024 | 504 | 3.110 |
Why?
| Cholangitis, Sclerosing | 8 | 2022 | 71 | 2.970 |
Why?
| Pancreatic Neoplasms | 20 | 2024 | 882 | 2.830 |
Why?
| Cholangiocarcinoma | 7 | 2021 | 77 | 2.680 |
Why?
| Bile Ducts, Intrahepatic | 5 | 2021 | 65 | 2.020 |
Why?
| Drainage | 9 | 2023 | 165 | 1.930 |
Why?
| Bile Ducts | 9 | 2019 | 67 | 1.920 |
Why?
| Biliary Tract Surgical Procedures | 4 | 2021 | 25 | 1.880 |
Why?
| Endoscopy, Gastrointestinal | 12 | 2023 | 219 | 1.840 |
Why?
| Constriction, Pathologic | 15 | 2022 | 228 | 1.740 |
Why?
| Gallstones | 4 | 2018 | 31 | 1.350 |
Why?
| Microscopy, Confocal | 8 | 2021 | 310 | 1.300 |
Why?
| Pancreas | 6 | 2021 | 306 | 1.290 |
Why?
| Biliary Tract Diseases | 4 | 2016 | 36 | 1.250 |
Why?
| Cholestasis | 7 | 2021 | 232 | 1.150 |
Why?
| Endoscopes | 3 | 2017 | 18 | 1.120 |
Why?
| Pancreatic Pseudocyst | 4 | 2018 | 13 | 1.120 |
Why?
| Carcinoma, Pancreatic Ductal | 5 | 2016 | 270 | 1.070 |
Why?
| Aged | 50 | 2025 | 22104 | 1.050 |
Why?
| Middle Aged | 57 | 2025 | 31155 | 0.990 |
Why?
| Adenocarcinoma | 7 | 2023 | 898 | 0.930 |
Why?
| Pancreatitis | 5 | 2024 | 129 | 0.910 |
Why?
| Endoscopy | 4 | 2015 | 285 | 0.910 |
Why?
| Retrospective Studies | 29 | 2025 | 14518 | 0.900 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 7 | 2019 | 55 | 0.890 |
Why?
| Endoscopes, Gastrointestinal | 8 | 2013 | 14 | 0.880 |
Why?
| Treatment Outcome | 28 | 2025 | 10230 | 0.860 |
Why?
| Duodenal Neoplasms | 1 | 2023 | 21 | 0.860 |
Why?
| Common Bile Duct Neoplasms | 1 | 2023 | 27 | 0.860 |
Why?
| Ampulla of Vater | 1 | 2023 | 38 | 0.850 |
Why?
| Choledochal Cyst | 2 | 2020 | 16 | 0.840 |
Why?
| Laparoscopy | 4 | 2021 | 451 | 0.840 |
Why?
| Humans | 106 | 2025 | 129652 | 0.830 |
Why?
| Adenocarcinoma, Mucinous | 2 | 2016 | 75 | 0.800 |
Why?
| Pancreatectomy | 3 | 2021 | 241 | 0.800 |
Why?
| Gastrointestinal Tract | 1 | 2025 | 185 | 0.790 |
Why?
| Catheterization | 8 | 2024 | 175 | 0.780 |
Why?
| Adenoma | 2 | 2023 | 214 | 0.780 |
Why?
| Cholangitis | 1 | 2022 | 20 | 0.760 |
Why?
| Male | 62 | 2025 | 63682 | 0.750 |
Why?
| Female | 64 | 2025 | 68777 | 0.740 |
Why?
| Calcinosis | 2 | 2019 | 230 | 0.680 |
Why?
| Cytodiagnosis | 1 | 2020 | 32 | 0.680 |
Why?
| Intestine, Small | 2 | 2019 | 150 | 0.640 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2020 | 315 | 0.630 |
Why?
| Artificial Intelligence | 1 | 2022 | 246 | 0.620 |
Why?
| Aged, 80 and over | 18 | 2025 | 7086 | 0.610 |
Why?
| Liver Neoplasms | 1 | 2023 | 640 | 0.600 |
Why?
| Lithotripsy, Laser | 2 | 2015 | 8 | 0.590 |
Why?
| Adult | 35 | 2025 | 35577 | 0.580 |
Why?
| Aneurysm, False | 1 | 2018 | 47 | 0.570 |
Why?
| Foreign Bodies | 1 | 2018 | 101 | 0.550 |
Why?
| Disposable Equipment | 1 | 2017 | 19 | 0.550 |
Why?
| Laser Therapy | 1 | 2018 | 131 | 0.530 |
Why?
| Polyethylene | 1 | 2016 | 11 | 0.510 |
Why?
| Biopsy | 6 | 2018 | 1097 | 0.500 |
Why?
| Gallbladder Diseases | 1 | 2015 | 9 | 0.490 |
Why?
| Gastroenterology | 4 | 2019 | 174 | 0.490 |
Why?
| Gastrointestinal Diseases | 5 | 2022 | 198 | 0.480 |
Why?
| Prospective Studies | 22 | 2023 | 7133 | 0.470 |
Why?
| Pancreatic Juice | 1 | 2014 | 2 | 0.470 |
Why?
| Learning Curve | 5 | 2019 | 68 | 0.460 |
Why?
| Biomarkers, Tumor | 2 | 2014 | 1181 | 0.460 |
Why?
| Postoperative Complications | 3 | 2022 | 2483 | 0.460 |
Why?
| Sphincterotomy, Endoscopic | 4 | 2019 | 27 | 0.450 |
Why?
| CA-19-9 Antigen | 1 | 2014 | 22 | 0.450 |
Why?
| Metals | 4 | 2023 | 128 | 0.440 |
Why?
| Sensitivity and Specificity | 9 | 2021 | 1838 | 0.440 |
Why?
| Hemorrhage | 1 | 2018 | 678 | 0.420 |
Why?
| Ultrasonography, Interventional | 3 | 2022 | 128 | 0.410 |
Why?
| Cholestasis, Intrahepatic | 1 | 2013 | 39 | 0.410 |
Why?
| Pancreatitis, Acute Necrotizing | 2 | 2023 | 12 | 0.390 |
Why?
| Follow-Up Studies | 12 | 2021 | 4897 | 0.390 |
Why?
| Predictive Value of Tests | 7 | 2017 | 1952 | 0.390 |
Why?
| Liver Diseases | 1 | 2014 | 290 | 0.370 |
Why?
| Anastomosis, Roux-en-Y | 2 | 2022 | 27 | 0.370 |
Why?
| Clinical Competence | 5 | 2019 | 1017 | 0.360 |
Why?
| Young Adult | 9 | 2025 | 12427 | 0.360 |
Why?
| Biliary Tract Neoplasms | 3 | 2016 | 25 | 0.350 |
Why?
| Foreign-Body Migration | 2 | 2006 | 35 | 0.300 |
Why?
| Natural Orifice Endoscopic Surgery | 3 | 2018 | 33 | 0.300 |
Why?
| Pancreatic Cyst | 3 | 2018 | 52 | 0.290 |
Why?
| Needles | 3 | 2019 | 57 | 0.290 |
Why?
| Gastrointestinal Hemorrhage | 2 | 2008 | 121 | 0.290 |
Why?
| B7-1 Antigen | 1 | 2008 | 61 | 0.290 |
Why?
| Video Recording | 4 | 2016 | 164 | 0.290 |
Why?
| Fluorouracil | 4 | 2020 | 199 | 0.280 |
Why?
| Bile Ducts, Extrahepatic | 2 | 2020 | 22 | 0.270 |
Why?
| Dilatation | 2 | 2018 | 60 | 0.270 |
Why?
| Gallbladder | 2 | 2022 | 17 | 0.270 |
Why?
| Adolescent | 11 | 2025 | 20394 | 0.260 |
Why?
| Abdominal Pain | 4 | 2023 | 144 | 0.260 |
Why?
| Cholelithiasis | 3 | 2015 | 36 | 0.250 |
Why?
| Hemostatic Techniques | 1 | 2005 | 45 | 0.230 |
Why?
| Indomethacin | 1 | 2024 | 78 | 0.230 |
Why?
| Peritoneal Neoplasms | 1 | 2005 | 87 | 0.230 |
Why?
| Catheters | 2 | 2015 | 68 | 0.230 |
Why?
| Ambulatory Care Facilities | 1 | 2006 | 228 | 0.220 |
Why?
| Guanidines | 1 | 2023 | 36 | 0.220 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2008 | 511 | 0.220 |
Why?
| Equipment Design | 9 | 2013 | 514 | 0.210 |
Why?
| Multiple Myeloma | 1 | 2005 | 125 | 0.210 |
Why?
| Esters | 1 | 2023 | 74 | 0.210 |
Why?
| Cholecystitis, Acute | 1 | 2022 | 23 | 0.200 |
Why?
| Prosthesis Implantation | 2 | 2019 | 145 | 0.200 |
Why?
| Self Expandable Metallic Stents | 1 | 2022 | 14 | 0.200 |
Why?
| Choledochostomy | 1 | 2022 | 11 | 0.190 |
Why?
| Quality of Life | 3 | 2023 | 2704 | 0.190 |
Why?
| Plastics | 2 | 2022 | 47 | 0.190 |
Why?
| Pain | 3 | 2022 | 789 | 0.190 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 339 | 0.190 |
Why?
| Multicenter Studies as Topic | 1 | 2022 | 286 | 0.180 |
Why?
| United States | 9 | 2017 | 13903 | 0.180 |
Why?
| Multivariate Analysis | 3 | 2021 | 1502 | 0.180 |
Why?
| Antimetabolites, Antineoplastic | 2 | 2020 | 91 | 0.180 |
Why?
| Tegafur | 1 | 2020 | 3 | 0.170 |
Why?
| Oxonic Acid | 1 | 2020 | 5 | 0.170 |
Why?
| Lasers | 1 | 2021 | 132 | 0.170 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2022 | 1368 | 0.170 |
Why?
| Logistic Models | 3 | 2021 | 1988 | 0.170 |
Why?
| Dissection | 2 | 2018 | 51 | 0.170 |
Why?
| ROC Curve | 2 | 2018 | 503 | 0.160 |
Why?
| Living Donors | 1 | 2022 | 287 | 0.160 |
Why?
| Hydrogen Peroxide | 1 | 2021 | 318 | 0.160 |
Why?
| Fiducial Markers | 1 | 2019 | 8 | 0.160 |
Why?
| Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| Carcinoembryonic Antigen | 2 | 2018 | 41 | 0.160 |
Why?
| Radiotherapy, Image-Guided | 1 | 2019 | 34 | 0.160 |
Why?
| Carcinoma, Squamous Cell | 1 | 2004 | 626 | 0.160 |
Why?
| Reproducibility of Results | 4 | 2019 | 3083 | 0.150 |
Why?
| Risk Factors | 6 | 2024 | 9765 | 0.150 |
Why?
| Anastomosis, Surgical | 1 | 2019 | 149 | 0.150 |
Why?
| Lasers, Solid-State | 1 | 2018 | 22 | 0.150 |
Why?
| Journal Impact Factor | 1 | 2018 | 29 | 0.150 |
Why?
| Cystadenoma, Serous | 1 | 2018 | 18 | 0.150 |
Why?
| Gastric Outlet Obstruction | 1 | 2017 | 9 | 0.140 |
Why?
| Fiber Optic Technology | 2 | 2015 | 17 | 0.140 |
Why?
| Neoplasm Recurrence, Local | 1 | 2023 | 964 | 0.140 |
Why?
| Cholecystectomy, Laparoscopic | 1 | 2018 | 51 | 0.140 |
Why?
| Hospitals, University | 1 | 2018 | 179 | 0.140 |
Why?
| Diagnosis, Differential | 3 | 2015 | 1434 | 0.140 |
Why?
| Parkinsonian Disorders | 1 | 2017 | 36 | 0.140 |
Why?
| Education, Medical, Graduate | 2 | 2019 | 438 | 0.140 |
Why?
| Urinary Incontinence | 1 | 2017 | 62 | 0.140 |
Why?
| Gastrointestinal Neoplasms | 2 | 2008 | 72 | 0.140 |
Why?
| Feasibility Studies | 4 | 2018 | 868 | 0.140 |
Why?
| Narrow Band Imaging | 1 | 2016 | 14 | 0.130 |
Why?
| Reoperation | 1 | 2019 | 545 | 0.130 |
Why?
| Neuroendocrine Tumors | 1 | 2018 | 99 | 0.130 |
Why?
| Time Factors | 3 | 2019 | 6556 | 0.130 |
Why?
| Neoplasm Staging | 6 | 2013 | 1295 | 0.130 |
Why?
| Gastric Bypass | 1 | 2017 | 107 | 0.130 |
Why?
| Regression Analysis | 1 | 2018 | 993 | 0.130 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 25 | 0.120 |
Why?
| Fellowships and Scholarships | 1 | 2019 | 273 | 0.120 |
Why?
| Cystadenoma, Mucinous | 1 | 2015 | 13 | 0.120 |
Why?
| Periodicals as Topic | 1 | 2018 | 204 | 0.120 |
Why?
| Cystadenocarcinoma, Mucinous | 1 | 2015 | 14 | 0.120 |
Why?
| Pathology, Clinical | 1 | 2015 | 36 | 0.120 |
Why?
| Radio Waves | 1 | 2015 | 17 | 0.120 |
Why?
| Single-Blind Method | 1 | 2016 | 271 | 0.120 |
Why?
| Pancreaticoduodenectomy | 1 | 2016 | 159 | 0.110 |
Why?
| Incidence | 2 | 2018 | 2644 | 0.110 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 1565 | 0.110 |
Why?
| Europe | 1 | 2014 | 364 | 0.110 |
Why?
| Length of Stay | 1 | 2019 | 1127 | 0.110 |
Why?
| Tertiary Care Centers | 1 | 2014 | 151 | 0.110 |
Why?
| Fluoroscopy | 3 | 2019 | 156 | 0.110 |
Why?
| Disinfection | 2 | 2018 | 117 | 0.100 |
Why?
| Double-Balloon Enteroscopy | 1 | 2013 | 1 | 0.100 |
Why?
| Databases, Factual | 1 | 2018 | 1269 | 0.100 |
Why?
| Colonoscopy | 2 | 2018 | 236 | 0.090 |
Why?
| Cyst Fluid | 2 | 2018 | 26 | 0.090 |
Why?
| Referral and Consultation | 2 | 2016 | 733 | 0.090 |
Why?
| Parkinson Disease | 1 | 2017 | 463 | 0.090 |
Why?
| Academic Medical Centers | 2 | 2017 | 481 | 0.090 |
Why?
| Technology Assessment, Biomedical | 2 | 2008 | 29 | 0.090 |
Why?
| Esophageal Neoplasms | 2 | 2005 | 295 | 0.090 |
Why?
| Cohort Studies | 2 | 2014 | 5420 | 0.090 |
Why?
| Deoxycytidine | 2 | 2013 | 165 | 0.090 |
Why?
| Chemoradiotherapy | 1 | 2013 | 210 | 0.090 |
Why?
| Catheter Ablation | 1 | 2015 | 335 | 0.090 |
Why?
| Carcinoma | 1 | 2013 | 217 | 0.090 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 101 | 0.090 |
Why?
| Child | 4 | 2018 | 20883 | 0.090 |
Why?
| Biopsy, Fine-Needle | 2 | 2008 | 68 | 0.090 |
Why?
| Radiography | 1 | 2013 | 798 | 0.090 |
Why?
| Practice Guidelines as Topic | 1 | 2018 | 1501 | 0.090 |
Why?
| Minimally Invasive Surgical Procedures | 2 | 2008 | 170 | 0.080 |
Why?
| Palliative Care | 2 | 2009 | 725 | 0.080 |
Why?
| Colorado | 2 | 2018 | 4421 | 0.080 |
Why?
| Abdominal Abscess | 1 | 2009 | 26 | 0.080 |
Why?
| Colonography, Computed Tomographic | 1 | 2009 | 6 | 0.080 |
Why?
| Risk Assessment | 4 | 2016 | 3240 | 0.080 |
Why?
| Prognosis | 3 | 2016 | 3794 | 0.080 |
Why?
| Capsule Endoscopy | 1 | 2008 | 18 | 0.080 |
Why?
| Decompression, Surgical | 1 | 2009 | 99 | 0.080 |
Why?
| Intestinal Perforation | 1 | 2008 | 45 | 0.080 |
Why?
| Duodenum | 1 | 2008 | 75 | 0.080 |
Why?
| Gastric Mucosa | 1 | 2008 | 52 | 0.070 |
Why?
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2008 | 12 | 0.070 |
Why?
| Tissue Fixation | 1 | 2008 | 34 | 0.070 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 32 | 0.070 |
Why?
| Wounds, Penetrating | 1 | 2008 | 63 | 0.070 |
Why?
| Equipment Safety | 4 | 2008 | 38 | 0.070 |
Why?
| Balloon Occlusion | 1 | 2008 | 34 | 0.070 |
Why?
| Immunoenzyme Techniques | 1 | 2008 | 213 | 0.070 |
Why?
| Medical Records Systems, Computerized | 1 | 2008 | 93 | 0.070 |
Why?
| Coloring Agents | 1 | 2007 | 77 | 0.070 |
Why?
| Radiotherapy, Intensity-Modulated | 1 | 2008 | 129 | 0.070 |
Why?
| Analgesics, Opioid | 1 | 2015 | 913 | 0.070 |
Why?
| Image Enhancement | 1 | 2008 | 167 | 0.070 |
Why?
| Rectal Neoplasms | 1 | 2008 | 136 | 0.070 |
Why?
| Liver | 2 | 2005 | 1839 | 0.060 |
Why?
| Duodenoscopy | 1 | 2006 | 7 | 0.060 |
Why?
| Laser Coagulation | 1 | 2006 | 57 | 0.060 |
Why?
| Intestinal Mucosa | 2 | 2008 | 590 | 0.060 |
Why?
| Anesthesia, General | 1 | 2006 | 54 | 0.060 |
Why?
| Tomography, X-Ray Computed | 2 | 2014 | 2535 | 0.060 |
Why?
| Prosthesis Design | 2 | 2009 | 306 | 0.060 |
Why?
| Conscious Sedation | 1 | 2006 | 85 | 0.060 |
Why?
| Ascites | 1 | 2005 | 44 | 0.060 |
Why?
| Acute Disease | 1 | 2008 | 980 | 0.060 |
Why?
| Thoracic Neoplasms | 1 | 2005 | 35 | 0.060 |
Why?
| Administration, Rectal | 1 | 2024 | 11 | 0.060 |
Why?
| Pain Management | 1 | 2008 | 327 | 0.060 |
Why?
| Equipment Failure | 1 | 2005 | 107 | 0.060 |
Why?
| Growth Substances | 1 | 2004 | 152 | 0.060 |
Why?
| Radiotherapy, Adjuvant | 3 | 2013 | 210 | 0.060 |
Why?
| Infant | 1 | 2018 | 9024 | 0.060 |
Why?
| Immunoglobulin A | 1 | 2005 | 200 | 0.050 |
Why?
| Chemotherapy, Adjuvant | 3 | 2013 | 381 | 0.050 |
Why?
| Liver Cirrhosis | 1 | 2006 | 280 | 0.050 |
Why?
| International Cooperation | 2 | 2017 | 174 | 0.050 |
Why?
| Child, Preschool | 1 | 2018 | 10517 | 0.050 |
Why?
| Pilot Projects | 1 | 2008 | 1587 | 0.050 |
Why?
| Neoplasm Metastasis | 1 | 2005 | 610 | 0.050 |
Why?
| Diagnostic Tests, Routine | 1 | 2003 | 102 | 0.050 |
Why?
| Necrosis | 1 | 2023 | 232 | 0.050 |
Why?
| Odds Ratio | 2 | 2016 | 1023 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2009 | 2742 | 0.050 |
Why?
| Combined Modality Therapy | 3 | 2013 | 1206 | 0.040 |
Why?
| Anti-Infective Agents, Local | 1 | 2021 | 42 | 0.040 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2004 | 254 | 0.040 |
Why?
| Disease-Free Survival | 2 | 2013 | 648 | 0.040 |
Why?
| Drug Combinations | 1 | 2020 | 330 | 0.040 |
Why?
| Double-Blind Method | 1 | 2023 | 1876 | 0.040 |
Why?
| Kaplan-Meier Estimate | 2 | 2013 | 857 | 0.040 |
Why?
| Myotomy | 1 | 2018 | 11 | 0.040 |
Why?
| Endoscopic Mucosal Resection | 1 | 2018 | 24 | 0.040 |
Why?
| Equipment Contamination | 1 | 2018 | 56 | 0.040 |
Why?
| Republic of Korea | 1 | 2017 | 29 | 0.040 |
Why?
| Administration, Oral | 1 | 2020 | 786 | 0.040 |
Why?
| Surgical Instruments | 1 | 2018 | 50 | 0.040 |
Why?
| Autopsy | 1 | 2017 | 94 | 0.030 |
Why?
| Bile | 2 | 2009 | 35 | 0.030 |
Why?
| Surgery, Computer-Assisted | 1 | 2018 | 76 | 0.030 |
Why?
| Prosthesis Failure | 2 | 2009 | 114 | 0.030 |
Why?
| United Kingdom | 1 | 2017 | 258 | 0.030 |
Why?
| Colonic Polyps | 1 | 2018 | 87 | 0.030 |
Why?
| Hospitalization | 1 | 2006 | 2070 | 0.030 |
Why?
| Cytokines | 1 | 2004 | 2017 | 0.030 |
Why?
| Videotape Recording | 1 | 2016 | 34 | 0.030 |
Why?
| Gastroenterologists | 1 | 2016 | 18 | 0.030 |
Why?
| Barrett Esophagus | 1 | 2018 | 148 | 0.030 |
Why?
| Radiologists | 1 | 2016 | 41 | 0.030 |
Why?
| Geriatric Assessment | 1 | 2017 | 205 | 0.030 |
Why?
| Quality Indicators, Health Care | 1 | 2018 | 298 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2008 | 5406 | 0.030 |
Why?
| Watchful Waiting | 1 | 2016 | 67 | 0.030 |
Why?
| Phantoms, Imaging | 1 | 2016 | 137 | 0.030 |
Why?
| Societies, Medical | 2 | 2008 | 751 | 0.030 |
Why?
| Disease Management | 1 | 2018 | 589 | 0.030 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 320 | 0.030 |
Why?
| Organoplatinum Compounds | 1 | 2013 | 41 | 0.030 |
Why?
| Leucovorin | 1 | 2013 | 69 | 0.030 |
Why?
| Injections, Intralesional | 1 | 2013 | 34 | 0.030 |
Why?
| Erlotinib Hydrochloride | 1 | 2013 | 70 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 875 | 0.030 |
Why?
| Camptothecin | 1 | 2013 | 109 | 0.020 |
Why?
| Comorbidity | 1 | 2017 | 1547 | 0.020 |
Why?
| Treatment Failure | 1 | 2013 | 340 | 0.020 |
Why?
| False Negative Reactions | 1 | 2011 | 53 | 0.020 |
Why?
| Quinazolines | 1 | 2013 | 244 | 0.020 |
Why?
| False Positive Reactions | 1 | 2011 | 114 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2013 | 769 | 0.020 |
Why?
| Colorectal Neoplasms | 1 | 2018 | 752 | 0.020 |
Why?
| Neoadjuvant Therapy | 1 | 2013 | 383 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2017 | 2717 | 0.020 |
Why?
| Stainless Steel | 1 | 2009 | 21 | 0.020 |
Why?
| Hematoma | 1 | 2009 | 54 | 0.020 |
Why?
| Observer Variation | 1 | 2010 | 315 | 0.020 |
Why?
| Alloys | 1 | 2009 | 33 | 0.020 |
Why?
| Terminally Ill | 1 | 2009 | 35 | 0.020 |
Why?
| Medical Laboratory Science | 1 | 2008 | 9 | 0.020 |
Why?
| Rupture | 1 | 2008 | 90 | 0.020 |
Why?
| Ligation | 1 | 2008 | 87 | 0.020 |
Why?
| Miniaturization | 1 | 2008 | 23 | 0.020 |
Why?
| Premedication | 1 | 2008 | 42 | 0.020 |
Why?
| Capecitabine | 1 | 2008 | 46 | 0.020 |
Why?
| Probability | 1 | 2009 | 306 | 0.020 |
Why?
| Evaluation Studies as Topic | 1 | 2008 | 173 | 0.020 |
Why?
| Total Quality Management | 1 | 2008 | 60 | 0.020 |
Why?
| Forms and Records Control | 1 | 2008 | 22 | 0.020 |
Why?
| Esophageal and Gastric Varices | 1 | 2008 | 37 | 0.020 |
Why?
| Radiotherapy Dosage | 1 | 2008 | 252 | 0.020 |
Why?
| Morbidity | 1 | 2008 | 302 | 0.020 |
Why?
| Remission Induction | 1 | 2008 | 272 | 0.020 |
Why?
| Safety Management | 1 | 2008 | 112 | 0.020 |
Why?
| Diarrhea | 1 | 2008 | 180 | 0.020 |
Why?
| Biopsy, Needle | 1 | 2007 | 189 | 0.020 |
Why?
| Injections | 1 | 2007 | 174 | 0.020 |
Why?
| Costs and Cost Analysis | 1 | 2007 | 201 | 0.020 |
Why?
| DNA | 1 | 2013 | 1400 | 0.020 |
Why?
| Survival Analysis | 1 | 2009 | 1274 | 0.020 |
Why?
| Information Dissemination | 1 | 2008 | 206 | 0.020 |
Why?
| Safety | 1 | 2007 | 331 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 663 | 0.020 |
Why?
| Prostheses and Implants | 1 | 2006 | 133 | 0.010 |
Why?
| Obesity | 1 | 2018 | 2883 | 0.010 |
Why?
| Receptors, Interleukin-8B | 1 | 2004 | 24 | 0.010 |
Why?
| Recurrence | 1 | 2007 | 1007 | 0.010 |
Why?
| Survival Rate | 1 | 2008 | 1877 | 0.010 |
Why?
| Esophagectomy | 1 | 2005 | 125 | 0.010 |
Why?
| Swine | 1 | 2006 | 760 | 0.010 |
Why?
| Positron-Emission Tomography | 1 | 2005 | 288 | 0.010 |
Why?
| Ischemia | 1 | 2004 | 406 | 0.010 |
Why?
| Epithelial Cells | 1 | 2004 | 1065 | 0.010 |
Why?
| Cells, Cultured | 1 | 2004 | 4083 | 0.010 |
Why?
| Biomarkers | 1 | 2008 | 3973 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2006 | 4063 | 0.010 |
Why?
| Animals | 1 | 2006 | 35361 | 0.000 |
Why?
|
|
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|